Non-interventional Study on Time to Response and Quality of Life in Relapsed/Refractory Multiple Myeloma When Treated With Lenalidomide in Second Line
NCT01430546
·
clinicaltrials.gov ↗
COMPLETED
Status
133
Enrollment
OTHER
Sponsor class
Conditions
Multiple Myeloma
Sponsor
Hareth Nahi